Total Payments
$199,408
2024 Payments
$10,684
Companies
60
Transactions
1,066
Medicare Patients
16,623
Medicare Billing
$1.2M
Payment Breakdown by Category
Research$138,059 (69.2%)
Other$33,709 (16.9%)
Food & Beverage$22,579 (11.3%)
Travel$2,902 (1.5%)
Gifts$2,132 (1.1%)
Education$27.75 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $138,059 | 8 | 69.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24,309 | 34 | 12.2% |
| Food and Beverage | $22,579 | 1,005 | 11.3% |
| Honoraria | $9,400 | 7 | 4.7% |
| Travel and Lodging | $2,902 | 5 | 1.5% |
| Gift | $2,132 | 3 | 1.1% |
| Education | $27.75 | 4 | 0.0% |
Payments by Type
Research
$138,059
8 transactions
General
$61,349
1,058 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $138,009 | 7 | $0 (2023) |
| Horizon Therapeutics plc | $18,687 | 61 | $0 (2023) |
| Lilly USA, LLC | $10,224 | 70 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $8,134 | 65 | $0 (2024) |
| Tandem Diabetes Care, Inc. | $5,371 | 29 | $0 (2024) |
| Abbott Laboratories | $2,237 | 129 | $0 (2024) |
| Tosoh Bioscience, Inc. | $2,132 | 3 | $0 (2019) |
| Novo Nordisk Inc | $2,081 | 132 | $0 (2024) |
| Dexcom, Inc. | $1,275 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,221 | 59 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,684 | 133 | Lilly USA, LLC ($4,867) |
| 2023 | $19,673 | 148 | Horizon Therapeutics plc ($9,090) |
| 2022 | $60,559 | 164 | Eli Lilly and Company ($48,800) |
| 2021 | $94,015 | 152 | Eli Lilly and Company ($88,955) |
| 2020 | $1,462 | 62 | Horizon Therapeutics plc ($261.83) |
| 2019 | $4,608 | 182 | Tosoh Bioscience, Inc. ($1,566) |
| 2018 | $4,407 | 131 | Tandem Diabetes Care, Inc. ($933.88) |
| 2017 | $4,001 | 94 | Tandem Diabetes Care, Inc. ($1,950) |
All Payment Transactions
1,066 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $113.66 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Diabetes Care | ||||||
| 12/10/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.96 | General |
| Category: Insulin Pump | ||||||
| 12/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Bone Health | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Durable Pump | ||||||
| 11/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Diabetes | ||||||
| 11/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE 365 SENSOR KIT (RETAIL) (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $15.08 | General |
| 10/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus, Tresiba | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Biological | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: DIABETES | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITH TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-2) | Eli Lilly and Company | $104,067 | 4 |
| A PHASE 3, MULTICENTER, RANDOMIZED, PARALLEL-DESIGN, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3209590 AS A WEEKLY BASAL INSULIN COMPARED WITH INSULIN DEGLUDEC IN PARTICIPANTS WITH TYPE 1 DIABETES TREATED WITH MULTIPLE DAILY INJECTION THERAPY | Eli Lilly and Company | $33,688 | 2 |
| EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITH TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (SURMOUNT-2) | Eli Lilly and Company | $253.95 | 1 |
| EX9536-4388 | Novo Nordisk AS | $50.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,866 | 2,746 | $457,050 | $187,892 |
| 2022 | 24 | 3,360 | 4,259 | $518,039 | $205,890 |
| 2021 | 27 | 5,444 | 9,980 | $972,330 | $413,975 |
| 2020 | 27 | 5,953 | 10,547 | $849,550 | $430,797 |
Total Patients
16,623
Total Services
27,532
Medicare Billing
$1.2M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 490 | 764 | $175,720 | $70,806 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 649 | 915 | $146,400 | $56,720 | 38.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 244 | 244 | $36,600 | $19,122 | 52.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 121 | 121 | $36,320 | $14,619 | 40.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 227 | 518 | $33,670 | $13,368 | 39.7% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 57 | 59 | $12,685 | $6,329 | 49.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 40 | $5,200 | $2,537 | 48.8% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 19 | 46 | $5,175 | $1,813 | 35.0% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2023 | 15 | 15 | $3,600 | $1,615 | 44.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 17 | 24 | $1,680 | $964.32 | 57.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 532 | 859 | $197,570 | $78,321 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 559 | 746 | $119,360 | $46,281 | 38.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 246 | 260 | $39,000 | $20,734 | 53.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 187 | 358 | $23,270 | $9,334 | 40.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 77 | 77 | $23,100 | $9,093 | 39.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 83 | 154 | $20,020 | $8,659 | 43.3% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 47 | 48 | $10,320 | $5,505 | 53.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 202 | 211 | $12,692 | $3,539 | 27.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $7,100 | $3,201 | 45.1% |
| 10005 | Fine needle aspiration biopsy using ultrasound guidance, first growth | Office | 2022 | 28 | 28 | $6,720 | $2,913 | 43.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 237 | 247 | $9,349 | $2,604 | 27.9% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 21 | 62 | $6,975 | $2,574 | 36.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 176 | 187 | $8,972 | $2,501 | 27.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 48 | 69 | $4,830 | $2,120 | 43.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 186 | 196 | $6,811 | $1,900 | 27.9% |
About Dr. Senan Sultan, M.D
Dr. Senan Sultan, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366461543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Senan Sultan, M.D has received a total of $199,408 in payments from pharmaceutical and medical device companies, with $10,684 received in 2024. These payments were reported across 1,066 transactions from 60 companies. The most common payment nature is "" ($138,059).
As a Medicare-enrolled provider, Sultan has provided services to 16,623 Medicare beneficiaries, totaling 27,532 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Specialist|Internal Medicine
- Location Jacksonville, FL
- Active Since 07/19/2006
- Last Updated 02/04/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1366461543
Products in Payments
- TEPEZZA (Drug) $18,687
- JARDIANCE (Drug) $17,185
- t-slim insulin pump (Device) $2,933
- t:slim X2 Insulin Pump with Control-IQ (Device) $2,349
- 25-OH Vitamin D ST AIA-Pack (Medical Supply) $2,132
- FARXIGA (Drug) $1,169
- Omnipod (Device) $1,022
- Ozempic (Drug) $905.23
- FREESTYLE LIBRE 3 (Device) $778.88
- Minimed 670G System (Device) $557.67
- Dexcom G6 Transmitter (Medical Supply) $550.47
- MINIMED 780G (Device) $527.88
- FreeStyle Libre (Device) $509.60
- Korlym (Drug) $486.05
- UNITHROID (Drug) $485.05
- Tymlos (Biological) $437.92
- Tresiba (Drug) $432.21
- AFREZZA (Drug) $376.62
- INVOKANA (Drug) $364.90
- GVOKE PFS (Drug) $362.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Jacksonville
Dr. Mae Sheikh-Ali, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.2M
Endocrinology, Diabetes & Metabolism $1.2M
Dr. Wasim Deeb, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $373,299
Endocrinology, Diabetes & Metabolism $373,299
Dr. Ricardo Silva, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $65,145
Endocrinology, Diabetes & Metabolism $65,145
Susan Samson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,917
Endocrinology, Diabetes & Metabolism $37,917
Dr. Melissa Morgan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $34,294
Endocrinology, Diabetes & Metabolism $34,294
Dr. Firas Warda, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $24,766
Endocrinology, Diabetes & Metabolism $24,766